EP Patent

EP0274431A2 — Drug delivery compositions and methods

Assigned to Quixote Corp · Expires 1988-07-13 · 38y expired

What this patent protects

Drug delivery compositions yield new and unexpected degrees of stabilization, solubilization and delivery of incorporated medicaments, drugs, or other physiologically-active compounds. The composi­tions enable administration of drugs and other medic­ally useful compounds via a va…

USPTO Abstract

Drug delivery compositions yield new and unexpected degrees of stabilization, solubilization and delivery of incorporated medicaments, drugs, or other physiologically-active compounds. The composi­tions enable administration of drugs and other medic­ally useful compounds via a variety of routes. More particularly, a drug delivery system or composition including one or more monomeric or polymerized sur­face active agents allows for rapid dissolution and smooth liberation of any desired incorporated drug or combinations, and the method of preparing the drug composition. In one embodiment, the physiologically-­active compound is encapsulated by a coacervate-derived film, and the finished product is suitable for trans­mucosal administration. Other formulations of this invention may be administered via inhalation, oral, parenteral and by transdermal routes.

Drugs covered by this patent

Patent Metadata

Patent number
EP0274431A2
Jurisdiction
EP
Classification
Expires
1988-07-13
Drug substance claim
No
Drug product claim
No
Assignee
Quixote Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.